Indolent Lymphoma
Feature
The ASCO Annual Meeting Starts This Week
More than 7000 abstracts were submitted for this year’s meeting a new record — and over 5000 were selected for presentation.
From the Journals
ASTRO Releases New EBRT Guideline for Symptomatic Bone Mets
Recommendations concerning pain management and quality of life are part of the guidance.
Feature
Obesity and Cancer: Untangling a Complex Web
Is gaining weight later in life better or worse for cancer risk than being overweight or obese from a young age?
Feature
Does More Systemic Treatment for Advanced Cancer Improve Survival?
Researchers evaluate whether patients treated in practices with higher rates of systemic therapy for very advanced disease have longer survival....
Feature
Urine Tests Could Be ‘Enormous Step’ in Diagnosing Cancer
Cancer biomarkers in urine are not nearly as widely studied as those in the blood, but a new wave of urine tests suggests research is gaining pace...
Feature
Chatbots Seem More Empathetic Than Docs in Cancer Discussions
AI gives readable, high quality, and empathetic responses to social media queries about cancer.
News
FDA Broadens Breyanzi’s Follicular Lymphoma Indication
For adults with relapsed/refractory follicular lymphoma, the FDA has approved an expanded indication for Breyanzi.
Conference Coverage
Survey Spotlights Identification of Dermatologic Adverse Events From Cancer Therapies
Survey respondents classify and grade morbilliform, psoriasiform, and papulopustular rashes based on a review of photographs and text descriptions...
Conference Coverage
New mRNA Vaccines in Development for Cancer and Infections
Different forms and designations of mRNA vaccines are used, depending on the application and desired effect.
From the Journals
Can a Risk Score Predict Kidney Injury After Cisplatin?
Researchers have developed a risk algorithm to predict acute kidney injury after cisplatin administration and tested it using data from six US...
From the Journals
Do Patients Benefit from Cancer Trial Participation?
Researchers conduct a meta-analysis comprising 141 comparisons of an investigational drug and a control treatment, which include immunotherapies...